Top Biomed Stock Signal: CELC
Report Date: 05-21-2022
Symbol: CELC - Celcuity Inc.
Sector:
Industry:
Top Biomed Stock Signal: CELC
Celcuity Inc. (CELC)
16305 36th Ave N Ste 100
Minneapolis, MINNESOTA 55446
Phone: 17633920767
Website: http://www.celcuity.com
CEO: Mr. Brian F. Sullivan
NASDAQ, Nasdaq Capital Market
Celcuity, Inc. is cellular analysis company. The company is headquartered in Minneapolis, Minnesota and currently employs 26 full-time employees. The firm is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the targeted therapy that best treats it. CELx platform provides traditional molecular diagnostics, which provides a snapshot of the genetic mutations present in a patient’s tumor because they analyze dead cells. Using dead cells prevents molecular diagnostics from analyzing in real-time the dynamic cellular activities, known as cell signaling, that regulate cell proliferation or survival.